Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.

NCT02161406 is registered in ClinicalTrials.gov with Dinesh Khanna, MD, MS as lead sponsor.

NCT NCT02161406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Lead sponsor
Dinesh Khanna, MD, MS
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
October 17, 2018
Enrollment
88 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse cutaneous systemic sclerosis